Professor Nikolai Petrovsky is an accomplished immunologist, vaccine developer, and clinical researcher with decades of experience in his field. He holds a double degree in medicine and surgery and completed his PhD in immunology. He has also contributed over 220 peer-reviewed articles to academic journals.

In 2002, Professor Petrovsky founded Vaxine, an Australian biotech company specialising in vaccine development, which developed a COVID-19 vaccine called COVAX-19 which was authorised for emergency use in Iran.

In this episode of BASED, Professor Petrovsky shares his expertise in vaccine tech and viruses and his views on Australia’s COVID-19 pandemic response.

Ver todos los episodios